Clinical Trials Logo

Clinical Trial Summary

This is a pilot randomized control trial of the UCLA PEERS protocol delivered via Telehealth with teens with neurofibromatosis type 1 whose parents report that they have difficulty making and keeping friends.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT04860362
Study type Interventional
Source University of Wisconsin, Milwaukee
Contact Bonita P Klein-Tasman, PhD
Phone 414-229-3060
Email [email protected]
Status Recruiting
Phase N/A
Start date January 29, 2021
Completion date August 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01362803 - AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors Phase 1/Phase 2
Completed NCT00352599 - Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1) Phase 1
Recruiting NCT03531814 - Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1 (NF1) on Clinical Treatment Trials N/A
Active, not recruiting NCT00846430 - Medical Treatment of "High-Risk" Neurofibromas Phase 2
Recruiting NCT03433183 - SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors Phase 2
Completed NCT03310996 - Non-invasive Stimulation in Neurofibromatosis Type 1 N/A
Recruiting NCT03406208 - Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing N/A
Recruiting NCT02544022 - Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (PNs)
Completed NCT02153931 - Internet Support Group for Parents of a Child With Neurofibromatosis Type 1
Active, not recruiting NCT01650142 - Modifying Genes in Neurofibromatosis 1 N/A
Recruiting NCT04879160 - Systematically Assessing Changes in Plexiform Neurofibroma Related Disfigurement From Photographs of Subjects With Neurofibromatosis Type 1 on a Phase 2 Clinical Trial
Not yet recruiting NCT04750928 - Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas Phase 1/Phase 2
Enrolling by invitation NCT01445314 - Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments
Recruiting NCT04561765 - Innovation in the Treatment of Persistent Pain in Adults With NF1: Implementation of the iCanCope Mobile Application- Clinical Trial N/A
Recruiting NCT04395495 - RASopathy Biorepository
Recruiting NCT01885767 - Neurofibromatosis (NF) Registry Portal
Recruiting NCT03981510 - Comparison of Gastrointestinal Motility in Healthy Children and Children With Constipation N/A
Recruiting NCT03741101 - Treatment of NF1-related Plexiform Neurofibroma With Trametinib Phase 2
Completed NCT00076102 - Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas Phase 2
Completed NCT03298438 - Study About Annoucement of the Diagnosis of Neurofibromatosis 1 in de Novo Forms N/A